AI Vaccine: This technology has also passed the crucial stage of first human testing.

(AI Vaccine will end the pandemic)

AI Vaccine: Artificial intelligence (AI) is no longer limited to chatbots, image generation, or data analysis. Its role in the healthcare sector is also rapidly expanding. After identifying diseases and developing new medicines, AI has now taken a major step forward in vaccine manufacturing. Scientists claim to have developed the world's first AI-designed vaccine that has the potential to provide protection not only against a single virus but against an entire family of viruses.

Researchers at the University of Cambridge in the UK, working with the biotech company DIOSynVax , developed this new technology. They say the vaccine could protect against existing viruses as well as new variants and potentially dangerous viruses that may emerge in the future.

This technology has also passed the crucial stage of the first human trial. Initial clinical trials have shown the vaccine to be safe, and it will now be tested on a larger scale in over 200 people.

A new era in vaccine development

Until now, most vaccines have been developed specifically for a specific virus or strain. While this strategy has saved millions of lives, viruses constantly mutate. This is why vaccines for diseases like the flu and COVID-19 require periodic updates.

Researchers believe that under the current system, scientists are always chasing viruses. By the time a new virus is identified, a vaccine is developed, and the infection reaches the public, it has already spread widely.

According to Professor Jonathan Heaney of the University of Cambridge, the COVID-19 pandemic has shown that we can develop vaccines quickly, but the thinking is still old-fashioned. Their goal is to develop a vaccine that can target the entire virus family.

How did AI prepare this vaccine?

For this project, scientists analyzed genomic data on coronaviruses collected from around the world, including information on past outbreaks, current infections, and animal viruses that could infect humans in the future.

AI and machine learning systems analyzed this genetic data to identify which parts of the virus remain virtually unchanged over long periods of time. Scientists were looking for elements so crucial to the virus's survival that changes in them would weaken the virus itself.

Based on this analysis, the researchers created a special super-antigen. An antigen is a component that teaches the body's immune system to recognize an enemy.

While typical vaccines are based on antigens from a single virus, this new antigen was designed to take into account shared characteristics of several related coronaviruses. Scientists believe that a vaccine made this way could remain effective even after major genetic changes in the virus.

What is Universal Sarbeco Vaccine?

The vaccine used in the human trials is called the Universal Sarbeco Coronavirus Vaccine. Sarbecoviruses are a family of coronaviruses that includes SARS-CoV-2, the virus responsible for COVID-19, the virus that caused the 2003 SARS epidemic, and several other coronaviruses found in bats.

This vaccine targets shared biological characteristics of the entire group of viruses rather than targeting a single virus. This allows the body's immune system to recognize and fight multiple related viruses, rather than just one.

What were the results of the first human trials?

According to the study published in June, the primary objective of the Phase 1 trial was to assess the vaccine's safety. The trial involved healthy volunteers aged 18 to 50 years.

The vaccine, a DNA-based formulation, was delivered through a specialized microfluidic jet system. This technology eliminates the use of traditional needles, but instead uses a high-pressure liquid stream to deliver the vaccine under the skin.

During testing, the vaccine was found to be safe and generated immune responses against several types of coronaviruses. Importantly, immune activity was observed not only against SARS-CoV-2 and SARS, but also against some bat-borne coronaviruses that may pose a future threat.

Although scientists acknowledged that the immune response was still preliminary, Phase 1 trials aim to evaluate safety and initial effects. Future larger trials will further assess its effectiveness.

How can it help prevent future pandemics?

Researchers believe that if the common characteristics of a virus family are identified in advance, a vaccine against it can be prepared before the epidemic spreads.

Today, surveillance programs around the world collect data on thousands of viruses in humans and animals. By analyzing this data with the help of AI, scientists can predict potential threats and develop preventative measures. The goal of this strategy is to prepare for a pandemic, not just react after it occurs.

Will this technology also work against bird flu and Ebola?

Researchers are now applying this platform to other dangerous viruses. Most prominently, bird flu (H5N1), which has affected birds, mammals, and humans in many parts of the world. Scientists say that many different strains of bird flu exist, and some variants have proven extremely deadly to humans.

This AI-based technology could help develop a comprehensive protection against such variants. The platform is also being tested against the Ebola virus family. Current vaccines are not equally effective against all types of Ebola viruses. The researchers' goal is to develop a vaccine that provides protection against the entire virus family.

Can it revolutionize the health sector?

Although this technology is still in its early stages and large-scale trials are pending, scientists consider it a major breakthrough in vaccinology. If further trials are successful, future vaccines could be developed that provide protection against entire virus families rather than just a single disease.

This will allow the world to be prepared in advance, rather than having to race to develop a vaccine after an epidemic has already occurred. This new AI-based approach points to a future in healthcare where humans can be one step ahead of viruses, not behind them.